All4NutraNo products in the cart.
All4NutraStartseite » News » Dry Powder Inhalers (DPI) » Page 4
Introduction Many respiratory pathogens enter the body through the respiratory tract, the lungs and the mucosal immune system are promising...
Abstract The dynamics of cohesive particles and their tendency to adhere to surfaces present significant challenges in various industrial processes....
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) continue as public health concerns. Inhaled drug therapy for TB has substantial...
Abstract Drug delivery is essential to provide correct treatments in many ways. The critical points in any drug delivery method...
Abstract Tuberculosis (TB) is an airborne bacterial infection caused by Mycobacterium tuberculosis (M. tb), resulting in approximately 1.3 million deaths in 2022...
Abstract The contributions of fine excipient materials to drug dispersibility from carrier-based dry powder inhalation (DPI) formulations are well acknowledged,...
Abstract The aim of this study was to investigate how the propensity for aerosolisation in binary adhesive mixtures was affected...
Abstract Background Nanocrystals can be produced as a dry powder for inhalation (DPIs) to deliver high doses of drug to...
Introduction Dry powder inhalers (DPI) are gaining popularity in the field of pulmonary treatments due to their numerous advantages. Compared...
Abstract The aim of this study was to develop a new respirable powder (RP) formulation of pirfenidone (PFD) with sustained...
Copyright: PharmaExcipients AG